Stay updated with breaking news from Codx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,900,000 shares, a growth of 24.2% from the March 15th total of 1,530,000 shares. Based on an average trading volume of 451,800 shares, the short-interest ratio is presently […]
Co-Diagnostics (NASDAQ:CODX – Get Rating) updated its first quarter 2022 earnings guidance on Thursday. The company provided earnings per share guidance of $0.170-$0.200 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.110. The company issued revenue guidance of $21 million-$22 million, compared to the consensus revenue estimate of $21.28 […]
Zacks Investment Research upgraded shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) from a hold rating to a buy rating in a report published on Tuesday, Zacks.com reports. They currently have $7.00 price target on the stock. According to Zacks, “Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics […]
HC Wainwright restated their buy rating on shares of Co-Diagnostics (NASDAQ:CODX – Get Rating) in a report published on Friday morning, TipRanks reports. The firm currently has a $15.00 target price on the stock. A number of other research firms have also recently commented on CODX. Sidoti began coverage on shares of Co-Diagnostics in a […]
Co-Diagnostics (NASDAQ:CODX – Get Rating) issued its quarterly earnings results on Thursday. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.12 by $0.13, Fidelity Earnings reports. Co-Diagnostics had a return on equity of 50.81% and a net margin of 40.11%. During the same quarter last year, the firm […]